Home About us Contact
|
Home About us Contact | ||
|
|
||
Regulatory Measures (regulatory + measure)
Selected AbstractsRegulatory measures against Erwinia amylovora in Switzerland,EPPO BULLETIN, Issue 2 2005B. Duffy Switzerland joined the list of fireblight-affected European countries in 1989. Vigorous and systematic steps were taken to limit the impact of the disease on fruit production and amenity plants. These efforts are codified in a Swiss law detailing prevention, eradication, control measures and issues of compensation. As with many Swiss legal directives, there is a defined coordination of federal and cantonal responsibilities and, in the case of fireblight, there is also an emphasis at all levels on personal responsibility of owners of susceptible objects (e.g. nurseries, orchards, host plants). Extension activities have been a key component in achieving compliance with disease management regulations and in obtained public support for control efforts. Agroscope FAW Wädenswil has taken a leading role in this respect through its website http://www.feuerbrand.ch. [source] Global Stakeholders: corporate accountability and investor engagementCORPORATE GOVERNANCE, Issue 2 2004Duncan McLaren In this age of transnational capitalism most victims of corporate malpractice have no means to hold the wrongdoers to account , especially those whose lives are blighted day-in, day-out by the "normal" operations of companies within the letter of the law. This paper argues that corporate social and environmental abuses are rooted in a lack of accountability of corporations to their stakeholders. It explores how governance mechanisms such as corporate engagement by "socially responsible" investors could enhance stakeholder accountability. It identifies and contrasts two paradigms in socially responsible investment engagement, and relates them to voluntary and regulatory responses to corporate abuses. It concludes that the development of standards for stakeholder-oriented engagement and governance could help stimulate effective regulatory measures to protect stakeholder interests. [source] Bemisia tabaci in CroatiaEPPO BULLETIN, Issue 1 2002T. Masten Bemisia tabaci was reported for the first time in the Mediterranean part of Croatia in 2000. It was found in glasshouses in the agricultural area between the towns of Trogir and Omis, on the following crops: Euphorbia pulcherrima, Thunbergia grandiflora, Cucumis sativus (cucumber), Solanum melongena (aubergine), Phaseolus spp. (beans), Ficus carica (fig), Rubus spp. and several weeds of the families Asteraceae and Solanaceae. In 2001, monitoring for the pest was organized all over the country, in each of the 21 counties. In each county, there were several monitoring points so that all the major vegetable and flower producers were included. A special effort was made to record the spread of B. tabaci in the region where it was first found, bearing in mind that optimal conditions for outdoor spread exist along the Adriatic coast. Yellow sticky traps and visual inspection are used to monitor for B. tabaci. Eradication measures are being applied, and regulatory measures have been taken to prevent further spread of B. tabaci to continental parts of Croatia. [source] An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United KingdomINTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT, Issue 4 2005Elias Mossialos The regulation of pharmaceutical markets is an important policy concern in many countries, and is generally undertaken with cost containment, efficiency, quality and equity objectives in mind. This article presents an overview of the demand-side and supply-side regulatory measures that have been introduced in four European countries, namely France, Germany, the Netherlands and the United Kingdom. More specifically, after considering some of the trends in pharmaceutical expenditure in these four countries over recent decades, the article considers the policies that have been introduced to influence patient demand, health care provider behaviour and the pharmaceutical industry. Since many of the policies are concurrently applied, it is difficult to assess the isolated impact of each, particularly because the effect of particular policies may often be country specific. However, it is clear that there is no overriding perfect solution to balancing the cost containment, efficiency, quality and equity objectives in pharmaceutical policy. No one policy or policy combination is right for all countries, and different countries will need to meet their own objectives through policy approaches that reflect their own particular environment. Copyright © 2005 John Wiley & Sons, Ltd. [source] Resource Availability, Commitment and Environmental Reliability & Safety: A Study of Petroleum RefineriesJOURNAL OF CONTINGENCIES AND CRISIS MANAGEMENT, Issue 1 2005Frederick Wolf This paper examines the effect of resource availability and resource commitment on several important regulatory measures related to environmental risk and safety performance in petrochemical manufacturing. The research is grounded in Normal Accident Theory, and it controls for the effect of interactive complexity and a coupling on environmental reliability. The study is based on a sample (n=70) of petroleum refineries located in the United States during the five-year period, 1993,97. A statistically significant (p=.01) relationship between resource availability and the incidence of accidental hazardous substance releases was observed. The study also identified a significant relationship between plant safety as measured by Total Case Incident Rates (TCIR) and resource availability. Surprisingly, no significant relationships were observed between accidental hazardous substance releases or safety related performance outcomes as measured by Total Case Incident Rates and resource commitment as capital spending related to health, environmental and safety in this sample of refineries. [source] Adulteration of Chinese herbal medicines with synthetic drugs: a systematic reviewJOURNAL OF INTERNAL MEDICINE, Issue 2 2002E. Ernst Abstract.,Ernst E. (University of Exeter, Exeter, UK). Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review (Review Article). J Intern Med 2002; 252: 107,113. The popularity of Chinese herbal medicines (CHMs) demands a critical analysis of safety issues. The aim of this systematic review is to summarize data regarding adulterations of CHMs with conventional drugs. Literature searches were carried out in six databases. Articles containing original data on adulterations were considered without language restrictions. Eighteen case reports, two case series and four analytical investigations were identified. The list of adulterants contains drugs associated with serious adverse effects like corticosteroids. In several instances, patients were seriously harmed. One report from Taiwan suggests that 24% of all samples were contaminated with at least one conventional pharmacological compound. It is concluded that adulteration of CHMs with synthetic drugs is a potentially serious problem which needs to be addressed by adequate regulatory measures. [source] Closing the open sea: Development of fishery management in four Icelandic fisheriesNATURAL RESOURCES FORUM, Issue 1 2003Thórólfur Matthíasson The article outlines the development of Iceland's fishery rights and the extension of its territorial waters between the 1950s and the mid-1970s, whereby Iceland gained exclusive control and use of the marine resources of the waters within 12, later 50, and ultimately 200 nautical miles around the island. The article concentrates on four of Iceland's main fisheries: shrimp, herring, capelin and cod. These four fisheries are discussed separately and in depth, presenting the beginnings and growth of the industry and detailing the development of management practices and the corresponding legislation and regulatory measures. Iceland's initial concern was to gain control over the marine resources surrounding the island, but once this was achieved, the focus of attention shifted to managing first the economic and soon also the ecological aspects of its tremendous resource. Informed mainly by indigenous expertise, Iceland's concern was to limit overfishing, manage its fisheries sustainably both from the economic and ecological points of view, and find the best ways to distribute the revenues from the marine harvest. The article looks at each of the four fisheries to clarify how the individual transferable quota (ITQ) system came into being, how initial quota holdings were allotted, and analyses the circumstances under which the ITQ system became the management tool of choice. For each fishery, the process of regulatory evolution was quite unique. At the same time, there is a common pattern to all the fisheries, which may be summarized as follows. Firstly, serious attempts to reform management practices only got underway when the fishery had collapsed or was close to collapse. Secondly, stakeholders invariably started the process of regulation by limiting access to the fishery. Thirdly, a variety of rules were implemented to allocate rights to participate in the fishery to additional entrants once membership had been closed. Finally, prior to the invention of the ITQ system, prices were used to manage fisheries in Iceland. It may be concluded that the management of fisheries by ITQs may be a historical accident, rather than the end point of a logical evolution. [source] Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year periodBRITISH JOURNAL OF CLINICAL PHARMACOLOGY, Issue 1 2009Emanuel Raschi WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT , Several noncardiovascular drugs with QT liability are currently on the market. , Previous epidemiological studies have shown significant exposure of the general population to drugs with QT liability with similar consumption in many European countries. , Several regulatory measures have concerned medicinal products carrying a pro-arrhythmic risk in humans. WHAT THIS STUDY ADDS , The list of antibacterial agents with documented QT liability has grown over the last few years. , Notwithstanding stringent regulatory measures, population exposure to antibiotics with QT liability is still significant in several countries. , The magnitude of the problem is clearly heterogeneous, with remarkable diversity between Northern and Southern countries (lower and higher exposure, respectively). AIMS (i) To classify antibacterial agents with QT liability on the basis of the available evidence, and (ii) to assess trends in their consumption over an 8-year period (1998,2005) in 14 European countries. METHODS Current published evidence on QT liability of antibiotics was retrieved through MEDLINE search and joined to official warnings from regulatory agencies. Each drug was classified according to an already proposed algorithm based on the strength of evidence: from group A (any evidence) to group E (clinical reports of torsades de pointes and warnings on QT liability). Consumption data were provided by the European Surveillance of Antibacterial Consumption (ESAC) project and were expressed as defined daily doses per 1000 inhabitants per day (DID). RESULTS Among 21 detected compounds, nine [six fluoroquinolones (FQs) and three macrolides (MACs)] belonged to group E. Use of group E drugs ranged from 1.3 (Sweden) to 4.1 DID (Italy) in 1998 and from 1.2 (Sweden) to 6.5 DID (Italy) in 2005. Significant exposure was observed in Italy and Spain (6.5 and 3.8 DID, respectively, in 2005). Only Denmark, Sweden and UK showed a slight decrease in use. Exposure to clarithromycin increased in 10 out of 14 countries, with a marked increment in Italy (3 DID in 2005). CONCLUSIONS Notwithstanding regulatory measures, in 2005 there was still significant exposure to antibacterials with strong evidence of QT liability and, in most countries, it was even increased. This warrants further investigation of appropriateness of use and suggests closer monitoring of group E drugs. Physicians should be aware when prescribing them to susceptible patients. [source] End-of-pipe or cleaner production?BUSINESS STRATEGY AND THE ENVIRONMENT, Issue 8 2007An empirical comparison of environmental innovation decisions across OECD countries Abstract While both fundamental types of abatement measure mitigate the adverse environmental impacts of production, cleaner production technologies are frequently more advantageous than end-of-pipe technologies for environmental and economic reasons. This paper analyzes a variety of factors that might enhance firms' propensity to implement cleaner production technologies instead of end-of-pipe technologies. On the basis of a unique facility-level data set derived from a recent OECD survey, we find a clear dominance of cleaner production in seven OECD countries: 76.8% of the facilities report that they invest predominantly in cleaner production technologies, above all in new production processes, but not so much in new products. Based on a discrete choice model, our estimation results indicate that regulatory measures and the stringency of environmental policies are more important for end-of-pipe technologies, while cost savings, general management systems and specific environmental management tools tend to favor clean production. We conclude that improvements towards cleaner production may be reached by the continuous development and wider diffusion of these management tools. Improvements may also be stimulated by widening the cost gap between the two types of technology, for instance by additionally charging for waste and energy use. Copyright © 2006 John Wiley & Sons, Ltd and ERP Environment. [source] | |||||||||||||